Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2550]

FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer

FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer

Research team present fundamental technology to remove metastatic traits from lung cancer cells

Research team present fundamental technology to remove metastatic traits from lung cancer cells

Researchers uncover an unexpected T cell exhaustion factor driving cancer immunotherapy resistance

Researchers uncover an unexpected T cell exhaustion factor driving cancer immunotherapy resistance

Stress-tolerant cells drive tumour initiation in pancreatic cancer

Stress-tolerant cells drive tumour initiation in pancreatic cancer

Artificial intelligence tool developed to predict risk of lung cancer

Artificial intelligence tool developed to predict risk of lung cancer

Dual-energy CT iodine concentration differentiates lung cancer from pulmonary metastases

Dual-energy CT iodine concentration differentiates lung cancer from pulmonary metastases

Scientists detail major mechanism lung cancers use to evade immune attack

Scientists detail major mechanism lung cancers use to evade immune attack

Genetic code change drives common lung cancer type

Genetic code change drives common lung cancer type

Experts explain treatment options for a common cancer complication

Experts explain treatment options for a common cancer complication

Enzyme inhibition promotes bone formation and curbs the development of bone metastases

Enzyme inhibition promotes bone formation and curbs the development of bone metastases

More from ecancer